3,0
31. März 2016
Aktueller Mitarbeiter, mehr als 10 Jahre
London, England
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Optimistic culture leading people to believe in a bright future. Several recent drug approvals and more to come. Compensation on par with competition in most areas.
Kontras
CEO is too dominating and not accepting people with opinions against his own. Because CEO has hired extensively from his former company Roche a big chunk of 'old' talent in the organisation has left or is on the verge of leaving.